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Abstract 
This paper investigates Critical Success Factors that affect the performance of organisations 
involved in Medical Technology supply chains (MTSCs) in Germany. The Medical 
Technology sector in Germany is considered an innovative, fast-growing and promising 
industry, being third behind the USA and China as the biggest market in the world, worth 
29.9 billion euros in 2017. MTSCs in this country are under pressure from health service 
funding and cheaper imports, primarily from China. Consequently, supply chain success is of 
high importance and OEM operational improvements are critical. This exploratory study 
involved a multiple case study approach where 15 OEMs within German MTSCs were 
investigated.  Following within-case and cross-case analysis, empirical results led to the 
development of testable propositions, which constitute a foundation for further research 
investigation. The findings show that there are six, prioritised Critical Success Factors for 
MTSCs that include sales and operations planning, product development process, and quality 
and compliance. These findings challenge existing assumptions about Critical Success Factors 
within MTSCs, providing practitioners with strategies showing that re-prioritised CSFs should 
improve operational performance of OEMs. 
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1. Introduction 
Medical Technology is any technology applied to save the lives of people affected by a wide 
array of conditions (Medtech Europe, 2017) and ranges from mass production items such as 
sticking plasters, syringes or latex gloves, to specific equipment such as wheelchairs and 
hearing aids, to high-tech devices such as pacemakers, replacement joints for knees and hips, 
to intelligent contact lenses (Eucomed, 2015; Medtech Europe, 2017). Medical Technology is 
considered to be an innovative, fast-growing and promising industry, particularly so in 
Germany as it is the third largest market in the world behind the United States of America and 
China (BVMed, 2018). In addition to some large companies, around 1,200 small and medium-
sized enterprises (SMEs) constitute the core of the sector (BMBF, 2017), with 93% of the 
organisations providing work for less than 250 employees.  In 2017, the total sales volume of 
Medical Technology organisations rose to 29.9 billion euros, with an export rate of 64% 
(BVMed, 2018). 
Despite this impressive growth, the Medical Technology industry in Germany is faced with a 
number of challenges. Reportedly, Germany’s statutory health insurance fund (gesetzliche 
Krankenversicherung) has experienced funding difficulties, forcing administrators to reduce 
fees and thus expenditures on Medical Technology (Hartford, 2014; Focus, 2016). 
Furthermore, manufacturers rely strongly on new product development to sustain or increase 
their market share, and with products having lifecycles not longer than 3 years, short 
development times and regulatory approvals become critical issues (Hempel, 2017; BVMed, 
2018). Additionally, Chinese and Indian companies are also lined up to be frontrunners in terms 
of cost, workforce, and market capture, pressuring German manufacturers to produce and 
distribute cost-efficient devices (Marucheck et al, 2011; Hempel, 2017). In this environment, 
the search for rationalisation potential becomes critical. Studies (J & M, 2010) show that a 
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defined supply chain strategy often falls short in this sector. Major deficiencies reported are 
the absence of a formulated strategy, the lack of efficient planning and coordination processes, 
along with unreliable sales forecasts.  
Understanding which key features lead to better performance of organisations within Medical 
Technology Supply Chains (MTSCs) is therefore imperative. In this paper, we investigate 
multiple cases of OEMs involved in MTSCs and use the results of the analysis to identify those 
Critical Success Factors (CSFs) that practitioners in the field prioritise in pursuing 
opportunities and areas of improvement which require addressing during the design and 
implementation of their Supply Chain Management (SCM) strategies. These findings are then 
fully discussed in the light of the extant literature. 
This paper is organised as follows: Section 2 presents a review of the literature. Section 3 
provides a detailed description of the methodology and case study design. Section 4 presents 
the findings, data analysis, and discussion within the context of literature on CSFs in SCM. 
Section 5 concludes the paper with implications for theory and management practice along 
with research limitations and avenues for further research. 
 
2. Literature review 
Supply chain management as an area in operations management literature is extremely well 
served (Kache & Seuring, 2014; Sweeney et al, 2015) whereas there is a real dearth regarding 
its focus on Medical Technology supply chains and their agility as exemplified, over some 
time, by literature (Rivard-Royer et al, 2002; Bakker et al, 2008; Gligor, 2014; Mandal, 2017). 
 
2.1 Healthcare & Medical Technology Supply Chains 
Mentzer et al (2001, p. 4) define supply chains as a “set of three or more entities directly 
involved in the upstream and downstream flow of products, services, finances, and information 
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from a source to the customer”. There are three major players in the Medical Technology 
supply chain: producers (product manufacturers), purchasers (group purchasing organisations, 
or GPOs, and wholesalers/distributors), and health care providers (hospital systems and 
integrated delivery networks, or IDNs) (Burns et al, 2002). The manufacturers (producers) in 
the supply chain can be broadly classified into three groups namely, pharmaceutical, medical-
surgical, and device manufacturers, the latter being the object of this study. Their products are 
then purchased by group purchasing organisations (GPO), wholesalers, distributors and in 
some cases independent contractors and delivered to providers like hospitals, IDNs, physicians 
(individual clinics) and pharmacies. Customers (payers) in this supply chain are local 
governments, employers, and individuals. They pay the providers through fiscal intermediaries 
like insurers, health maintenance organisations (HMOs) and pharmacy-benefit managers.   
 
 
 
Figure 1: Healthcare value chain (Burns et al, 2002) 
 
Smith et al (2012) provides a detailed view of the medical devices supply chain, in which the 
main product flows between the key players are clearly represented (see Figure 2), underlining 
the heavy influence of intermediaries or third-party players. 
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Figure 2: Detailed view of the medical devices supply chain (Smith et al, 2012, p. 3) 
 
 
Some notable and recent studies have focused on reverse logistics issues in supply chains, (Xie 
et al, 2018; Panjehfouladgaran et al, 2018; Cole et al, 2018). Studies by Burns (2000), Dacosta-
Claro (2002),  J and M Research (2010), and Mayr (2013) indicate that a significant portion of 
the costs associated with supply chains in the health care sector can be reduced by adopting 
strategies already deployed by the industry sector. In order to provide guidelines for 
practitioners to adopt the necessary organisational changes, the identification of Critical 
Success Factors becomes very important (Ngai et al, 2004). 
 
2.2 Critical Success Factors (CSFs) 
There are certain key elements in business that, if working properly, can ensure successful 
competitive performance for an organisation (Rockart, 1979). Rockart (1979) called these key 
areas Critical Success Factors (CSFs) and defined them as “areas or activities that should 
receive constant and careful attention from management”. According to Alazmi and Zairi 
(2003), CSFs are “areas in which results ensure successful competitive advantage”. CSFs are 
used, for example, to identify critical issues in planning implementation, to achieve better 
organisational performance, to assist managers to execute a better resource allocation, and to 
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serve as guidelines to monitor an organisation’s activities (Talib & Hamid, 2014; Boynton & 
Zmud, 1984). The concept of Critical Success Factors has been applied in several fields. 
Studies on CSFs can be found on Management Information Systems Planning (Munro & 
Wheeler, 1980), Knowledge Management (Wong, 2005; Alazmi & Zairi, 2003), New Product  
Design (Cheng & Shiu, 2008; Cooper & Kleinschmidt, 1995), Insurance Sales (Keck, Leigh, 
& Lollar, 1995), ERP implementation initiatives (Hong & Kim, 2002; Akkermans & van 
Helden, 2002), Project Management (Belassi & Tukel, 1996), Online Education (Volery & 
Lord, 2000), Six Sigma Implementation Initiatives (Coronado & Antony, 2002), Lean 
Implementation Initiatives (Achanga et al, 2006), Construction Projects (Sanvido et al, 1992), 
Business Process Management (Trkman, 2010), Total Quality Management (Antony et al, 
2002), and Environmental  Management  (Zutshi & Sohal, 2004), among many others.  
 
2.3 Critical Success Factors in Supply Chain Management  
Early applications of CSFs in logistics and SCM were first found in studies such as Cooper and 
Ellram (1993), Chiu (1995), Tate (1995), and Korpela and Tuominen (1996). In the field of 
SCM, Gunasekaran and Ngais’ (2003) work on a small third-party logistics (3PL) company in 
Hong Kong, they designed a framework for developing an efficient 3PL system, with factors 
such as ‘strategic planning’, ‘inventory management’, ‘transportation planning’, ‘capacity 
planning’, and ‘information management’ as the major dimensions.  Li et al (2006) investigated 
196 organisations and used structural equation modelling to develop five dimensions of SCM 
practice: ‘strategic supplier partnership’, customer relationship’, ‘level of information sharing’, 
‘quality of information sharing’, and ‘postponement’. Their work indicated that higher levels 
of SCM practice regarding these dimensions can lead to enhanced competitive advantage and 
thus provide organisations with improved organisational performance. Tummala et al (2006) 
discovered that resource allocation could be enhanced in areas such as information systems, 
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goal-setting, training, personnel, and aligning SCM initiatives with current priorities and 
committed resources. Cullen and Taylor (2009) proposed five factors (‘system quality’, 
‘information quality’, ‘management and use’, ‘world wide web – assurance and empathy’, and 
‘trust’) that practitioners perceive as successful for E-commerce. Furthermore, Power et al’s 
(2001) study of the CSFs that influence the agility of organisations in managing their SCs 
proposed several factors in an agile SCM: ‘customer satisfaction’, ‘average process changeover 
time’, ‘productivity’, ‘delivery in full on time’, ‘relative technological competitiveness’, ‘ratio 
of annual sales to average total stock’, ‘competitive advantage through process technology’, 
‘competitive advantage through ability to develop new products’, and ‘product innovation’. 
Hong et al’s (2008) work on the factors influencing performance of reverse supply chains 
(RSC) suggests that the ‘ease of use’, the ‘perceived usefulness’, the ‘service quality’, the 
‘channel relationship’, and the ‘reverse supply chain cost’ are the most important factors which 
influence the success of reverse supply chains.  
 
Hu and Hsu (2010) employed a survey on the electronics industry in Taiwan and factor analysis 
to identify 20 critical factors for implementing green SCM, which were then clustered into four 
dimensions: ‘supplier management’, ‘product recycling’, organisation involvement’, and ‘life 
cycle management’.  On a study on Green Supply Chain Management, Kim and Rhee, (2012) 
found that ‘planning and implementation’ as well as ‘collaboration with partners’ and 
‘integration of structure’ were key to a better performance of the organisations’ initiatives. Lin 
et al (2013) conducted a study in order to identify the critical enablers and pathways to higher 
performance in Supply Chain Management. They concluded that enterprises need to pay 
attention to two main pathways: a ‘compliance approach’ and a ‘voluntary approach’. Training 
programs, ISO, and suppler quality audit programs are suggested to address the former. As for 
initiating a voluntary effort in organisations, the authors suggest that firms need to instil 
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‘motivation’ into a supply chain quality system. Talib and Hamid (2014) conducted a literature 
survey and an analysis of 42 studies and proposed four major CSFs in SCM: ‘collaborative 
partnership’, ‘information technology’, ‘top management support’, and ‘human resources’. 
Finally, Nguyen (2017) conducted a literature survey based on a sample of 42 CSFs studies in 
several logistics and SCM fields, identifying ‘collaborative partnership’, ‘information 
technology’, ‘top management support’, and ‘human resource’ as Critical Success Factors. 
Table 1 presents a summary of CSFs in SCM as identified by previous researchers.  
 
Author/ 
year 
Research field Research 
method 
Identified Critical Success Factors 
Chiu (1995) Integrated Logistics  
Management System 
Survey/ 
Interviews 
 
Good logistics system planning; well-designed 
distribution system; prudent selection of allied 
companies; close relationship with trading partners; 
good logistics investment analysis; logistics 
management barriers elimination; top management 
support; continuous improvement in logistics 
 
Tate (1995) Logistics Partnership 
 
Interviews 
 
Operational/culture/value compatibility; understanding 
business needs; effective communication; mutual 
commitment; flexibility; fairness; trust 
 
Power et al, 
(2001) 
Agile Supply Chain Survey Participative management style; computer-based 
technology; resource management; continuous 
improvement enablers; supplier relation; Just-in-Time 
(JIT) methodology; technology utilization 
 
Gunasekaran 
and Ngai 
(2003) 
Small Logistics  
Companies 
Case study 
 
Strategic  planning;  inventory  management;  
transportation  planning;  capacity  planning;  
information management 
Chen and 
Paulraj 
(2004) 
Supply Chain Theory  
Advancement 
Literature 
review 
 
Environment  uncertainty;  customer  focus;  top  
management  support;  supply  strategy;  information 
technology; supply network structure; managing buyer-
supplier relationship; logistics integration  
Gunasekaran 
and Ngai 
(2004) 
Virtual Supply Chain Interviews Strategic alliance; web-based information system; 
automation for business process and  re-engineering; 
supply chain visibility; performance management 
system  
Ngai et al, 
(2004) 
Web-based Supply 
Chain 
Management 
Survey Communication; top  management  commitment;  
training  and  education;  data  security;  reliability of 
hardware and software 
Ogden (2006) Supply Base Reduction Case study Top management support; cross-functional teams; 
standardize part numbers and descriptions; supplier 
performance evaluation system; good communication 
during projects; win-win relationship; good information 
system; hiring right people 
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Author/ 
year 
Research field Research 
method 
Identified Critical Success Factors 
Tummala et 
al, (2006) 
Operational Issues in 
Supply Chain  
Management  
Implementation 
Survey Customer-supplier relationship; information and 
communication technology (ICT); re-engineering 
material flow; creating corporate culture; performance 
measurement 
Hong et al, 
(2008) 
Reverse Supply Chain  
(RSC) 
Survey 
 
Costs; technology capacity; government policy; 
organizational commitment; channel relationship; 
service quality; ease of use; perceived usefulness; RSC 
performance  
Kuei et al, 
(2008) 
Supply Chain Quality  
Management 
Literature 
review 
 
Customer focus; quality of IT system; supplier 
relationship; externally focused processed integration; 
supply chain quality leadership  
Cullen and 
Taylor (2009) 
E-commerce in Supply  
Chain 
Survey 
 
System quality; information quality; management and 
use; world wide web–assurance and empathy; trust 
Pettit and 
Beresford  
(2009) 
Humanitarian Supply  
Chain 
Literature 
review 
 
Strategic planning; resource management; transport 
planning; capacity planning;   information management; 
technology utilization; human resource management; 
continuous improvement; supplier relationship; supply 
chain strategy  
Wu and Hsu 
(2009) 
 
Collaboration in  
Integrated Circuit (IC)  
Supply Chain 
Literature 
review 
 
Authorization and  security;  CAD  and  EDA  tools;  
co-design  of  equipment  and  tools;  communication 
technology; database management; data format, 
transformation and interface; design for manufacturing; 
design optimisation and technique; information sharing 
mechanism; IP reuse; knowledge-based system; 
strategic alliance, community and coalition 
Hu and Hsu 
(2010) 
Green Supply Chain 
(GSC) 
Survey Supplier management; product recycling; organisational 
involvement; life cycle management 
Koh et al, 
(2011) 
ERP II Implementation 
in  
Supply Chain 
Interviews Operational efficiency; efficient legacy enterprise 
system; common partner goals; similar partner priority; 
collaboration partner support; partner trust; partner 
culture similarity; relationship change management; 
data standard consistency 
Lao et al, 
(2011) 
3PL Selection Survey Quality improvement; cost reduction; service quality; 
reputation; primary customer loyalty; complaint 
Dinter (2012) Information Logistics  
Strategy 
Survey Comprehensiveness; flexibility; top management 
support; communication; IT strategy orientation; 
business IT partnership; project collaboration 
Kim and 
Rhee (2012) 
Green Supply Chain 
(GSC) 
Survey Collaboration with partners; mutual trust; green 
business understanding; planning and implementation; 
standardising and integration; activation of supporting 
for GSC; strategic use of IT 
Mothilal et 
al, (2012) 
3PL Performance Survey Breadth  of  services; industry focus;  relationship  with  
3PLs; investment in  information system; skilled 
professionals; supply chain integration 
Lin et al, 
(2013) 
Supply Chain Quality  
Management 
Case study Supplier relationship; information technology; process 
management; top management support; human resource 
management; quality management; strategic planning; 
knowledge management 
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Author/ 
year 
Research field Research 
method 
Identified Critical Success Factors 
Thakkar et al, 
(2013) 
SCM in SME Case study Effective partnership; improve communication; 
logistics integration; supply chain business strategy; 
buyer-supplier relationship; effective  planning and 
control;  trust  among  supply chain  partners; 
availability of performance management tools  
Talib and 
Hamid  
(2014) 
Supply Chain  
Management CSF 
Literature 
review 
Top management support; human resource; information 
technology; collaborative partnership 
 
Gopal and 
Thakkar 
(2016) 
CSFs in sustainable SCs Structural 
modelling 
Identification of 25 leading and lagging CSFs in 
sustainability implementation in the Indian automobile 
industry 
Luthra et al, 
(2017) 
Green Supply Chain 
(GSC) 
Case study 
 
Internal management initiatives; customer support; 
regulation; supplier management; social commitment; 
supply chain competitiveness 
Luthra et al, 
(2018) 
CSFs in sustainability Structural 
modelling 
Identification of 16 diverse CSFs including Internal 
management initiatives; customer support; regulation; 
supplier management; social commitment; supply chain 
competitiveness 
Lou et al, 
(2018) 
SC excellence factors Delphi study SCM knowledge, education and supply chain culture 
 
Table 1: Critical Success Factors in SCM  
 
 
 
2.4 Critical Success Factors in the Medical Technology Industry 
Research on Critical Success Factors in the Medical Technology industry in recent years has 
been focused towards medical device development, as companies in this market face intense 
competition, higher degrees of customer sophistication, and where the cost of medical devices 
greatly influences healthcare systems (Medina et al, 2013). Medina et al (2012) distinguishes 
between internal and external factors influencing medical device development. Internal factors 
focus on the organisational context within which design is carried out. Lucke et al (2009) cites 
the level of experience of designers as a major internal factor, with Chatterji (2009) suggesting 
that companies started by former employees of established medical device industries perform 
significantly better than other new entrants as the former benefit from past experiences on 
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subjects such as regulatory strategy and marketing.  Another internal factor relates to the 
effectiveness of communication of development priorities (Brown et al, 2008), where a new 
product development process is proposed based on their findings. Similarly, Rochford and 
Rudelius (1997) and Millson and Wilemon (1998) conclude that the execution of a 
development process that encompasses preliminary market analyses, financial analyses, and 
customer involvement is critical for the commercial success of medical devices. 
In contrast, external factors relate mostly to cost and profit, research and development (R&D), 
clinical research, and insurance companies’ reimbursement (Advanced Medical Technology 
Association, 2003; Medina et al, 2013). Intellectual property protections and overseas market 
opportunities are identified, among others, as external factors (Medina et al, 2013).  Finally, 
the Food and Drug Administration (FDA), the regulatory agency of medical devices marketed 
in the Unites States, is suggested as the primary external factor influencing companies’ 
development priorities (Advanced Medical Technology Association, 2003; Medina et al, 
2013).  
 
To date, there has been no specific study on CSFs related to MTSCs available in the SCM 
literature. This paper directly addresses this urgent need from both the academic and 
practitioner perspectives.  
 
 
 
3. Methodology 
An exploratory research design was deployed, with a multiple case study approach selected for 
the following reasons. Firstly, the literature review revealed limited insights concerning CSFs 
in MTSCs. In such an embryonic research field, a qualitative research based on case studies 
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can provide better means to identify patterns and develop theory, especially if the relationships 
between the constructs are undefined (Edmondson & McManus, 2007). Secondly, as 
researchers are able to interact with respondents, perspectives are better understood and 
relevant processes can be closely investigated (Boyer & Swink, 2008). Thirdly, case studies 
encourage management involvement, which enables the researchers to generate managerially 
relevant knowledge. For these reasons, we followed established methodological guidelines for 
case study research (Gibbert et al, 2008; Eisenhardt, 1989; Voss et al, 2002). Fifteen in-depth 
case studies of manufacturing organisations were conducted to obtain a greater understanding 
of the main issues of German MTSCs. The nature of the case studies was exploratory in order 
to build theory that could later be tested using survey data (Ellram, 1996).  
 
3.1 Research Question 
This study was driven by the following research question: 
What are the Critical Success Factors (CSFs) for Original Equipment Manufacturers 
(OEMs) in German Medical Technology Supply Chains (MTSCs)? 
 
Robson (2011) suggests that studies focusing their efforts on answering ‘what’, ‘how’ and 
‘why’ questions call for a flexible, qualitative research design strategy. Following Robson 
(2011), this research question has been formulated specifying the population of interest (the 
MTSCs of German OEMs) and suggesting the nature of the study: exploratory rather than 
explanatory, as the focus of the research is to identify key variables (the aforementioned CSFs). 
Yin’s (2009) approach to qualitative research design was followed and key components and 
their application to the study are elucidated below. 
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Propositions 
Due to the exploratory character of the research question and the dearth of literature on the 
subject, no specific propositions regarding the CSFs were created before data collection. 
Eisenhardt (1989) supports the notion not to develop propositions in all types of exploratory 
research. This study therefore discusses and analyses the empirical results to develop testable 
propositions. 
 
Unit of Analysis 
The unit of analysis enables the establishment of construct validity and helps to select and 
gather the appropriate types of data and their sources (2009). The unit of analysis of this study 
has been defined as the OEMs within German MTSCs.  It is beyond the scope of this research 
to examine the perspectives of other actors in the German MTSCs (e.g., hospitals, third party 
sellers).  
 
 
3.2 Data Collection Design 
 The number of required cases suggested by several authorities differs; generally, the more 
cases utilised in a case study research, the higher the degree of certainty and therefore, external 
validity (Eisenhardt, 1989; Yin, 2009). Ellram (2012) considers that “six to ten cases should 
provide compelling evidence to support or reject an initial set of propositions” while Eisenhardt 
(1989) argues that “with no more than ten cases, it quickly becomes difficult to cope with the 
complexity and volume of the data”.  
Contact letters were sent to 25 organisations that appeared suitable for the study. 17 expressed 
their interest in participating in the study. An initial telephone interview was undertaken with 
all participants to ensure that they qualified for inclusion in the study. Due to scheduling 
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conflicts, two organisations were not available for an interview. Consequently, 15 
organisations were part of the study. Table 2  provides a summary of the participating 
organisations.  
 
Nr. Company 
Classification 
according to the 
GMDN Agency (2012) 
1 
Position of respondent 
Company size 
according to IfM 
(2017) 2 
Number of 
employees 
1 A Laboratory equipment Vice President of Supply Chain 
Small and Medium 
Enterprise (SME) 300 
2 B Electromechanical medical technology 
Vice President Global 
Logistics 
Large Enterprise 
(LE) 53 000 
3 C Electromechanical medical technology 
Manager of Logistics 
Planning 
Large Enterprise 
(LE) 12 500 
4 D Non-active implantable technology 
Director of Supply Chain 
Management 
Large Enterprise 
(LE) 3 400 
5 E Electromechanical medical technology Head of Supply Chain 
Large Enterprise 
(LE) 6 000 
6 F Reusable instruments Manager of Logistics Planning 
Large Enterprise 
(LE) 4 400 
7 G Hospital hardware Vice President of Global Logistics 
Large Enterprise 
(LE) 6 300 
8 H Biological-derived devices 
Manager of Global 
Logistics 
Large Enterprise 
(LE) 600 
9 I Non-active implantable technology 
Vice President of Supply 
Chain 
Small and Medium 
Enterprise (SME) 180 
10 J Electromechanical medical technology 
Head of Supply Chain 
Operations 
Small and Medium 
Enterprise (SME) 400 
11 K 
Diagnostic and 
therapeutic radiation 
technology 
Director of Supply Chain 
Management 
Large Enterprise 
(LE) 49 000 
12 L Single use technology Director of Supply Chain Small and Medium Enterprise (SME) 500 
13 M 
Healthcare facility 
products and systems 
adaptations 
Head of Supply Chain Small and Medium Enterprise (SME) 200 
14 N Anaesthetic and respiratory technology 
Director of Purchasing, 
Global Supply Chain 
Small and Medium 
Enterprise (SME) 200 
15 O Hospital hardware Head of Outbound Logistics 
Large Enterprise 
(LE) 15 200 
 
 
Table 2: Summary of the respondent demographics 
1 = (GMDN-Agency, 2012) 
2= (Institut für Mittelstandsforschung (IfM), Bonn, 2017) 
 
The primary data collection utilised semi-structured interviews (see Appendix I).  
Following Yin (2009), tests for construct validity, internal validity, external validity and 
reliability were performed. Table 3 below summarises all four tests and tactics adopted to 
ensure validity and reliability.  
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Tests Case study tactic 
 
Construct validity 
 
• Use multiple sources of evidence 
• Chain of evidence 
• Have respondents review draft case study report 
Internal validity • Use pattern matching 
• Address rival explanations 
External validity • Use replication logic 
Reliability • Use interview protocol 
 
 
Table 3: Case study design considerations - adapted from Yin (2009, p. 41) 
 
 
To ensure construct validity, multiple sources of evidence, chain of evidence, and informant 
reviews were used (Yin, 2009). The main respondents of each interview were the heads of 
SCM or other high-level executives. All 15 organisations represented OEMs from the German 
Medical Technology sector, but of variable size and specific products.  
 
For triangulation, qualitative and qualitative archival data in the form of company 
documentation (e.g. reports, procedures) and as well as publicly available material (e.g. annual 
reports, corporate websites) were collected and analysed. To ensure consistency during the 
application of the method, all interviews were arranged, conducted and summarised by the 
researchers. Following Robson (2011), interviews took no longer than 45 minutes and 
permission was sought from each participant to use a tape-recorder to record the interview. 
Once the data were summarised, they were sent back to each one of the organisations for 
review. Based on the feedback received from the respondents, minor changes were made to the 
interview data. The interview data were then translated from German into English. 
Confidentiality was an important prerequisite for all interviews and efforts were made to ensure 
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it. Permission was granted by the organisations involved to employ the interview data for 
analysis.   
 
In an effort to avoid researcher bias and increase internal validity, the authors shared the results 
during the course of the study among themselves and with their colleagues. The analysis of the 
case study data entailed the identification of patterns in the different cases and explaining why 
these patterns existed (Yin, 2009). Efforts were also made to address rival explanations. 
 
Replication logic was utilised in order to establish the domain to which a study’s findings could 
be generalised. Yin (2009) recommends using replication via multiple case design. The case 
studies characterised a wide range of companies, products, and services (Table 2). Instead of 
being limited to representing 15 data points in a quantitative study, each one of these case 
studies represented an experiment of its own (Yin, 2009; Ellram, 1996). Each of these 
organisations conducted SCM activities with several degrees of success and under many 
different conditions in order to improve their competitiveness. Regardless of their degree of 
success, a cross-case analysis made apparent that there are commonalities among the CSFs.   
Every step in the process was documented –interviews, data coding, details of any triangulation 
analysis, and the steps towards generalisation (Yin, 2009).  The case study protocol for the 
study was designed with the support of academics and colleagues, and adjusted with insights 
generated after the conclusion of the pilot phase. Notes, documents, tabular materials, and 
narratives constitute the elements of a case study database.  
 
3.3 Data Analysis  
Analysis and interpretation of field data are considered the core of theory building of case 
studies. Nonetheless, they constitute the most difficult part of the process (Eisenhardt, 1989), 
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as all data should be treated without bias while preserving their original meaning and context 
(Yin, 2009). The data analysis was conducted in two steps: within case and cross-case. All 
interviews were analysed following the three-step approach of Miles and Huberman (1994): 
data reduction, data display, and conclusion.  
Initial conclusions for each case were generated and documented separately. After individual 
firm profiles were obtained from within-case coding, a cross-case analysis was conducted (Yin, 
2009). Data were reduced to quotes, sentences and/or paragraphs that proved relevant to the 
research question (raw data themes). The raw data themes were clustered into descriptive high 
order themes such as ‘patient safety’, ‘forecast accuracy and accountability’, ‘capacity 
allocation’, among others. This allowed the researchers to identify major themes that served as 
a first indication of general issues considered important by the interviewed organisations, and 
to identify commonalities and differences between them. Furthermore, these major themes 
enabled the researchers to identify patterns and deduce general dimensions. Excerpts of the in-
depth analysis are found in Table 4, demonstrating how the researchers progressed from raw 
data themes over descriptive codes (higher order themes) to deducing CSFs grounded in and 
deduced from the SCM literature.  Coding was only regarded as complete once agreement 
between researchers was reached. 
 
Raw data themes Codes 
Main themes 
(CSFs) 
“Decisions regarding supply chain capacity allocation usually lead to very 
intensive discussions in the management team, particularly as there are still 
issues to solve in regard to our current approach to reviewing our forecasts 
on a quarterly basis. We are knowingly (or to some extent unknowingly) 
assigning tightly constrained resources to tasks that we already know today 
will not be next month’s priority, or even next week’s. Marketing and sales 
and operations do not usually trust each other’s figures, leading to more 
tension and counterproductive behaviours.” (Company G) 
Capacity 
allocation 
decision 
Sales and 
operations 
planning 
 19 
 
Raw data themes Codes 
Main themes 
(CSFs) 
“Teams in our design department are typically assessed on their speed in 
bringing a new product, technology, or customer service to the market, and 
on budget. It really comes down to two measures of success: speed and 
turnover.” (Company D) 
Measures of 
success 
Product 
development 
process 
“The supply chain organisation at corporate level has a tendency to point its 
finger at marketing and sales and saying ‘if you provided us with a more 
accurate forecast, we could run better operations and a better supply chain.’ 
What it is often left out of the picture is that there will always be a margin of 
forecast error. If the best we can achieve is 60 per cent forecast accuracy, 
then marketing and sales should be held accountable for 40 per cent of 
forecast error, but this is not done at all. If we had a fixed agreement on this, 
we could design our supply chain to be flexible enough to adjust to a 40 per 
cent forecast error rate.” (Company B) 
Forecast 
accuracy 
Sales and 
operations 
planning 
“Obviously our major target is to ensure that all the products we develop, 
manufacture and distribute to our customers are safe, user-friendly, and 
compliant with FDA regulations. Regulations are strict, and it really doesn‘t 
take a rocket scientist to figure out why. When people‘s lives are at stake, the 
appropriate tests must be strictly carried out. Observing safety compliance 
in product design is not enough: we need to make sure that we are meeting 
safety requirements at all steps of value creation”.  
(Company J) 
Patient safety 
Quality and 
compliance 
“Adding value is not always about meeting all customer demands at any time 
and at any price. It‘s also about having a formal agreement with the customer 
on terms and conditions. It’s about managing customer expectations when it 
comes to our products and services. It’s about making sure that well-intended 
people in the sales department don’t unnecessarily increase the complexity 
of operations for the design, scheduling, purchasing, production, and 
logistics departments.” (Company D) 
Management 
of customers‘ 
expectations 
Customer 
relationship 
management 
 
Table 4: Excerpts from coding 
 
3.4 Pilot Study 
Before beginning the main study, a pilot study was developed and conducted in order to explore 
topical and methodological issues, generate conceptual clarification for the research design, 
sharpen the focus of the research investigation, and test the effectiveness of the field procedures 
(Yin, 2009). It was not intended as a pre-test, but rather to assist the researchers in the fine 
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tuning of the planned lines of questions for the interview (Robson, 2011). Interviews were 
originally chosen as the main data collection method, which were conducted using a previous 
version of the questionnaire shown in Appendix 1. The interviews were piloted first with three 
participants of the 11th Innovation Transfer Operations System (ITOS) Summit celebrated in 
the spring of 2013 in Remscheid, Germany, where they were asked questions related to their 
supply chain activities. The summit helped to identify 15 respondents for the pilot study, all 
representing organisations from the medical technology sector in Europe and headquartered 
not only in Germany but also in Sweden and France.  
 
The pilot study was employed to streamline the research aim and to modify the questionnaire 
tool. One major change was related to the context of the case study. For practical reasons, it 
was decided to sharpen the focus of this research investigation to German OEMs of the medical 
technology sector located in Germany, as this study was originally intended to be conducted 
all over Europe. This modification benefited the overall results of the study, as it strengthened 
the conclusions generated after cross-case analysis in later stages of the study. The pilot study 
also contributed to the identification of several issues regarding the research approach. First, it 
confirmed that the interview approach, while time-consuming, was an appropriate method for 
this investigation, as face-to-face contact with the respondents and the on-site visits to each of 
the interviewed organisations appeared to be more meaningful than an anonymous survey 
approach. On the other hand, the total length of the interviews (over one hour in average) and 
the decrease of additional comments in the later questions suggested that the questionnaire 
should be shorter in order to encourage more meaningful answers. For this reason, the 
questionnaire tool was simplified to ensure that the total interview time would not exceed 45 
minutes. This simplification was achieved by eliminating questions that delivered only 
straightforward answers or seemed confusing to the respondents of the pilot study. Finally, it 
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was identified that only respondents that were contacted after the interview via telephone 
provided corrections or additions to the written summary of the interview. Respondents that 
were only contacted by email did not provide any feedback. Therefore efforts were made to 
contact all respondents during the main study via telephone. 
The results of the pilot study were presented at the 21st European Operations Management 
(Euroma) Conference on June 20th 2014 in Palermo, Italy (Garcia-Villarreal et al, 2014). 
 
 
 
4. Findings and Discussion  
Table 5 shows the Critical Success Factors that emerged from the analysis of data and compares 
them with extant literature on CSFs in the field of SCM. 15 CSFs were identified as a result of 
the cross-case coding process.  
The six most important CSFs which emerged from this research and their implications are 
discussed in this section in detail. 
 
4.1 Joint decision making to match demand and supply with S&OP  
Sales and operations planning is a both a cross-departmental and cross-organisational process 
that ranges over all operational areas of an organisation and requires inputs of both key supplier 
and customers (Sheldon, 2006). Sales and operations planning, if done right, improves end-to-
end supply chain performance (Sheldon, 2006). It is a process working twofold: it first creates 
a good overview of future demand trends on the basis of a demand forecast and using input 
from sales and key customers; then it develops a plan in order to match the forecast against the 
organisation’s existing production and distribution capacities. Matching demand against 
capacities helps to identify potential constraints, which are then discussed by the management 
team until consensus is reached and solutions are agreed on (Aparajithan et al, 2011). The 
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results are consolidated sales plans, production plans, inventory plans, new product 
development plans, strategic plans, and financial plans (Sheldon, 2006).  
 
Nine out of the 15 case companies provided strong evidence to support this factor as critical 
for success. Managers of almost all interviewed organisations have launched in recent years or 
are conducting at the moment improvement projects on this area. For instance, Company J 
reported lower inventories and more stable production rates with shortened lead times as 
benefits of a launched project that took over 3 years to complete. Company B reported that the 
alignment of all information flows between sales, planning, production, logistics and 
expedition is essential in order to achieve a reliable sales and operations plan.  Forecasting is a 
core activity of sales and operation planning. Company D developed a tool to compare the 
current forecast plan with the available capacity budget of all business units, avoiding 
production bottlenecks, minimising the cost of unsold goods, and increasing on-time delivery 
to the end customer.  As pointed out by Company O, structure, rigour, and the appropriate 
information platform are required for a functional S&OP process. Here, they set up meetings 
with clearly defined responsibilities, increased executive participation and visibility, as well as 
an information management tool that allowed them to gather and feed the appropriate inputs to 
the process. Company M reported on how top management participation in the process is 
essential for its success, as a final and timely decision on conflicting issues is often required in 
order to produce consensus on the plan. Company M also developed a standard set of rules, 
common performance indicators and appropriate incentives for all business units in order to 
improve the forecast accuracy and increase accountability in case of deviations. Sales and 
marketing play an important role to generate a more accurate sales and operations plan. After 
reaching the limits of its postponement strategy for customised products, Company E focused 
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on improving their pre-sale processes in an effort to offer end customers products that were 
easier to configure and to manufacture.   
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Critical Success Factor Description 
No. of Respondents 
(Company) 
Support from SCM literature 
 
Top management  
support 
 
Top level management support is required to design and implement appropriate changes in the supply chain, as 
decision makers at board level are more aware of an organisation’s strategic imperatives to remain competitive in 
the marketplace. Top management supports process improvements by committing time, personnel, and financial 
resources as well as by building commitment across all relevant functions (Power et al, 2001; Gunasekaran & 
Ngai, 2003; Chen & Paulraj, 2004).  
 
4 
(B, H, K, M) 
 
(Talib & Hamid, 2014), (Cai et al, 2003), 
 (Chen & Paulraj, 2004), (Chiu, 1995), (Dinter, 2012), 
(Gunasekaran & Ngai, 2003), 
(Hu & Hsu, 2010), (Lin et al, 2013), 
(Ngai et al, 2004), (Ogden, 2006), 
(Pettit & Beresford, 2009), (Power et al, 2001),  
(Soin, 2004), (Thakkar et al, 2013) 
 
Sales and operations   
planning (S&OP) 
 
Sales and operations planning helps decision makers to determine how much of which products to make, where 
to make them, and in which markets to distribute them based on demand forecasts, cost factors, and strategic 
objectives. S&OP supports strategic decision making on how to allocate supply chain capacity. It requires an 
appropriate information flow, segmentation of products and customers based on demand patterns, and leaders’ 
commitment to encouraging and modelling the right behaviours (Sheldon, 2006; Aparajithan et al, 2011). 
 
 
9 
(B, D, G, H, I,                            
J, K, M, O) 
 
(Chiu, 1995), 
(Gunasekaran & Ngai, 2003), 
(Gunasekaran & Ngai, 2004), 
(Thakkar et al, 2013), 
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Critical Success Factor Description 
No. of Respondents 
(Company) 
Support from SCM literature 
 
Information  
management 
 
Appropriate information systems support decision making in SCM in different ways, for instance, gathering and 
supporting the analysis of historical information (products, quantities, prices, suppliers,…), establishing 
appropriate metrics to measure supply chain performance, visualising expenditures across the supply chain, 
supporting standardisation efforts, among others. Web-based information systems in SCM reduce communication 
barriers among actors of the supply chain, thus enabling integration and support more accurate customer or 
supplier profiling. Conversely, information management systems are regarded as a main barrier in supply chain 
collaboration, due to incompatibility of IT applications among supply chain partners or inconsistent information 
(Gunasekaran & Ngai, 2003; Chen & Paulraj, 2004; Ogden, 2006; Dinter, 2012). 
 
2 
(B, M) 
 
(Talib & Hamid, 2014), (Chen & Paulraj, 2004), 
(Cullen & Taylor, 2009), (Dinter, 2012),  
(Gunasekaran & Ngai, 2003),  
(Gunasekaran & Ngai, 2004), (Kim & Rhee, 2012), 
(Koh et al, 2011), (Lin et al, 2013),  
(Mothilal et al, 2012),  
(Gunasekaran, & Nachiappan, 2012),  
(Ngai et al, 2004), 
(Ogden, 2006), (Pettit & Beresford, 2009), 
(Power et al, 2001), (Soin, 2004), 
(Thakkar et al, 2013), 
(Tummala et al, 2006), 
(Wu & Hsu, 2009) 
 
Procurement strategies 
 
Strategic purchasing is considered critical for the success of SCM, as purchasing decisions strongly impact 
strategic planning due to the quickly fluctuating competitive environment. Selecting appropriate suppliers entails 
choosing suppliers that can meet the needs of the organisation in terms of capacity, lead times, quality, 
manufacturing technology, price, service, among other criteria. Strategic purchasing is reported by literature as a 
condition to establish cooperative supplier relationships in order to enhance a firm’s competitive position. 
Furthermore, reducing the number of suppliers may prove beneficial to organisations, as win-win relationships 
can be developed with remaining suppliers, increasing leverage for the organisation (Power et al, 2001; Chen & 
Paulraj, 2004; Ogden, 2006; Kim & Rhee, 2012). 
 
 
5 
(C, D, J, K, O) 
 
(Chen & Paulraj, 2004), (Hu & Hsu, 2010), 
(Lin et al, 2013), (Kim & Rhee, 2012), 
(Koh et al, 2011), (Mothilal et al, 2012),  
(Ogden, 2006), (Power et al, 2001),                                           
(Soin, 2004), (Thakkar et al, 2013) 
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Critical Success Factor Description 
No. of Respondents 
(Company) 
Support from SCM literature 
 
Inventory  
management 
The stock of raw material, work-in-process, and finished goods can be better managed for all actors of a supply 
chain by adopting best practices such as just-in-time inventory systems, Kanban, VMI, and capacity requirements 
driven by delivery schedules of clients and consumer orders with a rolling horizon (Gunasekaran & Ngai, 2003).   
2 
(C, M) 
(Gunasekaran & Ngai, 2003) 
 
Developing and 
maintaining strategic 
partnerships 
 
The goal of developing and maintaining strategic partnerships with suppliers through collaboration in SCM is to 
have a common, transparent, and visible demand pattern. Minimising costs, improving service efficiency and 
effectiveness, improving revenue, and allowing for greater operational flexibility are some of the positive 
outcomes of collaboration. Collaboration is necessary to ensure a highly integrated and efficient logistics network 
for organisations and involves sharing information (products, volumes, designs, environment,) with suppliers as 
well as meeting regularly with key suppliers to establish common goals and to achieve both integration of 
information and standardisation. Organisations attempting to maintain strategic partnerships with suppliers should 
get suppliers under long-term contracts to make sure that the promised benefits are realised. Collaboration is not 
easy to implement, as lack of knowledge on with whom or when to collaborate and trust issues between partners 
are barriers to it (Chiu, 1995; Power et al, 2001; Chen & Paulraj, 2004; Ogden, 2006; Kim & Rhee, 2012). 
 
 
 
 
3 
(B, K, O) 
 
(Talib & Hamid, 2014), (Chen & Paulraj, 2004), 
(Chiu, 1995), (Kim & Rhee, 2012), (Koh et al, 2011), 
(Lin et al, 2013), (Ogden, 2006),  
(Power et al, 2001), (Pettit & Beresford, 2009), 
(Soin, 2004), (Thakkar et al, 2013), (Tate, 1995), 
(Tummala et al, 2006), (Wu & Hsu, 2009) 
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Critical Success Factor Description 
No. of Respondents 
(Company) 
Support from SCM literature 
 
Production system 
 
A production system allows an organisation to produce more products in the same or shorter time while ensuring 
the expected quality with less cost. A supply chain can benefit from shorter work cycles and from the elimination 
or reduction of all non-added value activities, as it increases the responsiveness of a supply chain to changes in 
the demand. A key concept in production systems relates to competitive priorities, in which manufacturing 
companies decide which manufacturing tasks or key competitive capabilities should be kept in-house. Decisions 
at this level are made based on cost, flexibility, quality, and delivery capabilities. The overall supply chain strategy 
can be benefited when decisions are not purely based on cost, but also on issues of flexibility, quality, innovation, 
speed, time, and dependability (Schönheit, 1997;   Tummala et al, 2006; Koh et al, 2011). 
 
 
5 
(A, B, C, D, H) 
 
(Koh et al, 2011), 
(Tummala et al, 2006) 
Product development 
process 
Decisions made during product design and development have an influence on the setup and degree of complexity 
of the supply chain that is required to support their delivery. The influence of product development is not only 
related to shorter time to market of products or more robust processes, but also to shorter production cycles for 
serial parts at the OEM production facilities. Benefiting from shorter lead times can be achieved through product, 
components, and production process standardisation. The role of physicians is also essential in device innovation, 
with collaboration between developers and physicians being of great importance in order to both reduce the 
complexity of production of devices and strengthen the relationship with the customer. Integration of suppliers in 
new product development has also been reported as important, with support ranging from giving minor design 
suggestions to being responsible for the complete design, development, and engineering of specific parts (Wu & 
Hsu, 2009).  
7 
  (A, D, E, H, I, J, O) 
 (Wu & Hsu, 2009) 
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Critical Success Factor Description 
No. of Respondents 
(Company) 
Support from SCM literature 
 
Training and                          
commitment of        
staff 
 
Training and experience of staff is an important issue in SCM, as having strategic thinkers and individuals with 
knowledge about the product and the marketplace lead to better results in strategic and operational decisions. 
Commodities should be managed by people knowledgeable of the product. In order to increase stakeholder buy-
in, cross-functional, autonomous teams are important, as they enhance the probability of stakeholders participating 
in the entire process, thus hindering thinking and acting in silos. Thus, stakeholders in a supply chain are more 
likely to approve changes when they provide input in shaping SC strategies (Ngai, Cheng, & Ho, 2004; Ogden, 
2006). 
 
4 
(A, D, M, O) 
 
(Talib & Hamid, 2014), (Cai et al, 2003), 
(Lin et al, 2013), (Ngai et al, 2004), (Ogden, 2006), 
(Pettit & Beresford, 2009), (Power et al, 2001), 
(Thakkar et al, 2013) 
 
Quality and   
compliance 
 
Safety and effectiveness of products are important issues for the Medical Technology sector. Companies must 
both validate their products and manufacturing practices in order to remain in the business. Agencies such as the 
U.S. Food and Drug Administration (FDA) are responsible of ensuring that manufacturers and products comply 
with current medical device laws. This becomes an important issue for SCM and poses a challenge for 
manufacturers, as they must satisfy the high demands on quality, traceability, and security. (BVMed, 2015; FDA, 
2014; Kuei & Madu, 2008). 
 
7 
  (C, D, F, G, J, M, N) 
 
(Kuei & Madu, 2008) 
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Critical Success Factor Description 
No. of Respondents 
(Company) 
Support from SCM literature 
 
Customer relationship 
management 
 
Customer relationship management is deployed to ensure that there is no gap between customer expectations and 
requirements and the delivery of products and services by the organisation in focus, so that these items can be 
made available on time as required. This entails forming strategic alliances with the customer, setting up frequent 
meetings between suppliers and customers, and shared information systems (Chen & Paulraj, 2004; Lin et al, 
2013). 
 
5 
(A, D, K, M, O) 
 
(Chen & Paulraj, 2004), (Kuei & Madu, 2008), 
(Lin et al, 2013), (Soin, 2004), 
(Tate, 1995) 
Distribution system A distribution strategy incorporates interactions among several actions in a supply chain. Each focal organisation 
has got its own unique network comprising of different actors, resources, and activities, both downstream and 
upstream. The position of each company in the supply chain with respect to others reflects on its capacity to 
provide value to others (e.g. innovation, productivity, flexibility, competence). A supply network structure is 
influenced by several factors, such as the task, authority issues, and coordination mechanisms across several firms 
or organisational units (Chen & Paulraj, 2004; Gunasekaran & Ngai, 2003; Thakkar et al, 2013). 
 
3 
(K, L, M) 
(Chen & Paulraj, 2004), (Chiu, 1995), 
(Gunasekaran & Ngai, 2003), 
(Lao et al, 2011), 
(Thakkar et al, 2013), 
Transport management Transport management influences the downstream, door-to-door operational processes of a supply chain and 
involves the core processes of shipping, forwarding, (de)consolidation, contract delivery, freight bill payment, 
warehousing, relocation, load tendering, and brokering Appropriate decisions regarding outsourcing this function 
or keeping it in the core business of an organisation can improve competitive advantage (Gunasekaran & Ngai, 
2003). 
4 
(A, D, E, H) 
(Chiu, 1995), (Gunasekaran & Ngai, 2003), 
(Pettit & Beresford, 2009), 
(Thakkar et al, 2013) 
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Critical Success Factor Description 
No. of Respondents 
(Company) 
Support from SCM literature 
 
Green Supply Chain 
 
A recent competitive motive within organisations in view of the impact of industrialisation is the adoption of 
supply chain practices and relationships that lead to impact the environment positively. These practices and 
relationships involve ‘green’ purchasing, ‘green’ manufacturing, ‘green’ materials management, ‘green’ 
distribution/marketing, as well as reverse logistics. This entails also the reuse, remanufacturing, and/or recycling 
of materials into new or other products with value in the market (Hu & Hsu, 2010;  Kim & Rhee, 2012; Singh & 
Shabani, 2016). 
 
 
1 
(M) 
 
(Hu & Hsu, 2010), 
(Kim & Rhee, 2012), 
(Singh & Shabani, 2016) 
Reverse logistics A supply chain process that is currently gaining more attention from academics, reverse logistics is a factor that 
helps to instil confidence in customers in the purchased goods. Organisations with outstanding after-sales 
services, including the return of goods for replacements or services can generate an advantage from their 
competitors (Gunasekaran & Ngai, 2003;  Hong, Suh, & Hou, 2008;  Singh & Shabani, 2016; Luthra et al, 
2017). 
2 
(K, M) 
(Gunasekaran & Ngai, 2003),  
(Hong, Suh, & Hou, 2008), 
(Singh & Shabani, 2016), 
(Luthra et al, 2017) 
    
 
Table 5: CSFs related to the respondents’ perception 
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One major barrier to implement a robust S&OP process is the ‘silo-mentality’ prevalent 
in organisations, where the targets of sales departments are at odds with the targets of 
operations (Sheldon, 2006). In order to free themselves from this barrier, Company O 
developed joint sales and operations goals and had the sales and production teams share 
the same workspace in order to encourage the right behaviours in the organisation.  
Regardless of their size and product range, the nine respondents considering this factor 
of critical importance face similar issues in terms of poor decision making and fire-
fighting actions in order to balance demand and capacities. Major barriers reported were 
conflicting targets within departments, poor master data quality, poor organisation of the 
master scheduling department, a lack of measurement of forecast quality, and planning 
with infinite capacities as a general approach.  
Based on the results of the analysis, we propose that: 
 
P1 Issues of balancing customer demand requirements and capacity allocation in 
the supply chain are raised by conflicting goals between departments within an 
OEM and between organisations in the supply chain of German MT. OEMs 
focusing on installing sustainable and robust Sales and Operation Planning 
systems have a competitive advantage over those who do not. 
 
 
4.2 Reduction of complexity in the design of products and manufacturing processes   
Medical Technology is one of the most research-intensive industries in Germany (BMBF, 
2017). The basis for the economic success of Medical Technology in Germany and abroad 
is the broad range of innovative products it creates. About a third of its revenues are 
generated from products that are less than three years old (BVMed, 2018). For this reason, 
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the product development process becomes crucial for the supply of innovative products 
to an organisation’s customers (Medina et al, 2013). Respondents consider this factor as 
highly critical, as the decisions made at the product development process stage account 
for 70-80% of the product’s final costs (Schönheit, 1997; Handfield & Nichols, 2002). In 
this context, designers play a major role (either consciously or unconsciously) in the setup 
of their supply chains and in their degree of complexity, but their influence is not only 
limited to the reduction of time to market with intelligent product design (Wu & Hsu, 
2009).  
 
From an economic point of view, the risk of lost margin rises with the increase of exotic 
parts and special constructions that should be later catered by the supply chain (Schönheit, 
1997).  Company D observed this phenomenon in their own operations and transitioned 
from an inwardly oriented model (first developing a product then searching for a market) 
to a more customer oriented model of product design (understanding customer needs and 
developing strategies to promote their products) while reducing the diversity of their 
product variants. Involving users in the innovation process can be beneficial to an OEM, 
as development time, product test and regulatory approval time, as well as development 
costs can be reduced (Lettl, 2013). Given the importance of the role of users in the design 
of products, Company D cooperates actively with surgeons in the design of medical 
devices and names their finished products after the physician that inspired or co-designed 
them. Activities in product development process have an influence on the performance of 
other organisational functions, such as procurement, manufacturing, marketing and sales, 
and service (Schönheit, 1997). Company A launched a project to standardise information 
flows between sales, product development, and procurement in order to reduce the risk 
of increasing their dependency to niche suppliers by increasing their supplier base. These 
 33 
 
efforts enhanced their material availability while reducing the risk of material 
obsolescence. The results were an increase of their order fulfilment and on-time 
deliveries. Company J analysed their product portfolio in an effort to standardise their 
raw materials and their part numbers, with the effect of decreasing their supplier base and 
streamlining their purchasing, order picking, and assembly processes. Company D 
focused on reducing manufacturing costs (technology, methods, and materials) through a 
re-examination of their product portfolio. Finally, Company H launched a project to 
improve their product update services in order to cut manufacturing, procurement, 
inventory, and after-sales costs. 
 
Six out of the 15 organisations interviewed have been actively working on shifting the 
focus from ‘developing the best possible product’ (Push) to ‘designing the most adequate 
product for physicians’ (Pull), an approach that required shifting paradigms present in 
German engineering organisations – getting away from a traditional engineer’s mentality 
(‘made in Germany’) to a more customer-oriented and thus economically meaningful 
approach to design. 
For these reasons, we propose that, 
 
P2. In order to reduce complexity of future operations, product design requires not 
only the involvement of physicians, health institutions, and regulatory agencies to 
enhance product functionality, but also the involvement of stakeholders of the 
supply chain, particularly manufacturing, sourcing, logistics, sales, and after sales 
services.  
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4.3 Efficient tracking and tracing of Medical Technology in the supply chain brings 
competitive advantage  
The Medical Technology sector is in a high pressure to deliver products that are safe and 
effective for patients. Agencies such as the U.S. Food and Drug Administration (FDA) 
are responsible of ensuring that manufacturers and products comply with current medical 
device laws (FDA, 2014). Due to the high demands regarding quality, traceability, and 
security, organisations are requested to deliver documented evidence that the quality 
criteria regarding processes and products have been fulfilled (BVMed, 2015) and that all 
manufactured parts can be re-traced, thus becoming an important issue in SCM.  
A factor rarely found in the reviewed SCM literature, ‘quality and compliance’ was 
regarded as critical for success by seven of the case study companies. Manufacturers of 
medical devices must ensure that their products do not put the lives of patients at risk. 
Audits and certifications are common instruments to promote quality design and 
manufacturing practices (FDA, 2014). National and international guidelines and laws also 
foresee the validation and qualification of systems (BVMed, 2018). Many decisions in 
SCM are influenced by these regulations, as errors can occur during the development, 
production, sterilisation, storage, transportation or utilisation of medical devices 
(Marucheck et al, 2011). Company F reports on the many measures they must take in 
order to avoid contamination or inadequate sterilisation during packaging, transportation, 
and handling. Decisions are also taken at a slower rate as in other industries. Company H 
noted that  decisions to expand critical manufacturing capacities or launching continuous 
improvement activities on the shop floor are, in comparison with other industries, at a 
much slower pace and subject to more detailed scrutiny before rollout. Company I 
reported on the pressures to balance the construction of new, innovative products that 
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meet market requirements while complying with costly and time-consuming (but 
necessary) regulations.  
 
Given the critical nature of medical devices and the potential harm failures during the 
production and distribution processes can cause, implementing effective tracking and 
traceability processes is critical.  Companies G, H, and N, all have designed, formalised, 
and validated processes and set up information management systems in line with the 
current technological trend of ‘Industry 4.0’. These systems are capable of collecting 
information and keeping track of products at all the stages of the supply chain (primary 
production by suppliers, incoming material, warehousing, production and assembly, 
sterilisation, warehousing, distribution, and utilisation by the customer) and represent an 
improvement over previous processes, which were characterised as being bureaucratic, 
time-consuming, inefficient, and employing manual systems. This turned into an 
advantage for these companies, as the regulatory requirements of the countries in which 
they sell their devices may vary and the timeliness and transparency of information is a 
decisive factor in this market. This, however, proved to be a very time consuming and 
costly exercise for Company M, a SME, which after three years of switching into a new 
information management system, has not benefited from this implementation. The 
authors propose that a future process flow design is an imperative requirement to 
determine which digital tools are required and valued by the customer (e.g. hospitals and 
clinics) and worth investing in and how much improvement potential is existent in order 
to reduce overhead cost in supply chain operations.  
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With these insights in mind, we propose that: 
 
P3. As supply chain visibility is a capability that customers are increasingly willing 
to pay for, selecting the appropriate tools requires process orientation. Providing 
hospitals and clinics with real-time information on product and spare parts 
shipping status can provide a competitive advantage for OEMs in the Medical 
Technology sector. 
 
 
4.4 Increasing leverage of OEMs with appropriate procurement strategies 
Both purchasing and materials management constitute basic strategic business processes 
critical for the success of SCM and not just a narrow support function to the overall 
business strategy (Reck et al, 1992). Although studies such as Bhakoo and Chan (2011) 
have investigated collaboration and e-commerce within healthcare, the Medical 
Technology devices has not been the focus. Purchasing portfolio models have recently 
become very popular in the field of professional purchasing (Caniels & Gelderman, 
2005), with Kraljic’s model for developing supply strategies (Kraljic, 1983) being one of 
the most known. In this model, organisations develop purchasing strategies based on their 
own strength and the strength of the supply market, resulting in three general purchasing 
strategies: exploit (in the case of buyer dominance), balance (in the case of a balanced 
relationship), or diversify (in case of supplier dominance) (Kraljic, 1983; Reck et al, 
1992). 
 
In the context of supply chain management, the employed procurement strategies play a 
major role in the creation of value for industries in the Medical Technology sector, as 
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medical devices have a relatively short life cycle in comparison with products from other 
industries (Thomas & Griffin, 1996). Company C developed an integrated approach 
towards procurement based on the phases of the product life cycle. In the product 
development phase, the focus of the purchasing department lies on the preselection of 
suitable suppliers and on the research of substitution materials while the R & D 
department focuses on designing modular products (Baukastenprinzip). During product 
market launch, procurement, product development, and logistics join efforts to ensure 
minimal stock and foster collaboration with suppliers in both the design and delivery of 
components. During market penetration, procurement has the tasks of searching for 
alternative suppliers in order to reduce the risk of stockouts. In the market saturation 
phase, the focus changes to cost optimisation through product standardisation and the 
arrangement of long-term contracts with suppliers. Finally, during product phase-out, the 
target of procurement and logistics is to minimise stock levels and avoiding material cost 
increases.  
 
Conventional procurement strategies (VMI, EDI, Just in Time, Supplier Kanban) are 
applied by almost all of the large enterprises involved in this research. All Case companies 
note that it is important to evaluate procurement strategies from a holistic perspective and 
consider the impact these might have in other organisations in the supply chain. In this 
context, selecting the right supplier involves more than looking for a supplier that can 
deliver goods at the lowest cost per piece; it involves a combination of criteria such as 
right quality, sufficient capacity, appropriate lead times and technology, price, and 
additional services. Company H warns on using low cost country sourcing as a 
procurement strategy, as lost margin can be generated at the very beginning of a project 
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when suppliers cannot deliver the agreed quality. Geographical distance, language and 
intercultural issues can also become barriers as well. 
 
Power relationships also play a role in the selection of the appropriate suppliers in the 
Medical Technology sector. Case companies C, D, and K have implemented Just in Time 
strategies with several degrees of success as a means to reduce stocks, forcing their 
suppliers to deliver raw material and components in small quantities and on immediate 
basis. Furthermore, Case companies D, K, and O have implemented VMI, making 
suppliers responsible for both stock overflows and stock-outs of at the OEMs’ warehouse 
facilities. In contrast, Companies L and M, both SMEs, are not strong enough to put 
pressure on suppliers to adopt such practices.  
Hence, we propose that: 
 
P4. Although procurement strategies such as VMI, Kanban, and JIT appear to be 
more beneficial for large German firms with power over suppliers, SMEs require 
their procurement strategies to be based on the product lifecycle in order to reduce 
the risk of inventory obsolescence. Cooperation and process knowledge exchange 
is beneficial for both OEMs and upstream organisations when designing and 
implementing alternative procurement strategies.   
 
 
4.5 CRM positively affects the configuration and complexity of SC operations 
Customer relationship management assists organisations in mining available customer 
data and information in order to understand customer requirements and to improve their 
value propositions. This involves collecting and logically using customer and other 
 39 
 
relevant data (the information process) to build a consistently superior customer 
experience and enduring customer relationships (Payne & Frow, 2005). This involves an 
integration of processes, people, operations, and marketing capacities (Swift, 2000). 
Several respondents noticed that the relationship with end customers has turned more 
complex in recent years. For instance, Company C has noted a shift of the way they do 
business with their customers. In the past, they would show up directly at a hospital with 
a new product in hopes that it would enthuse physicians and purchasing managers with 
its features and, based on this, they would negotiate prices and number of units to deliver.  
Nowadays they must negotiate prices with intermediaries such as Group Purchasing 
Organisations (GPOs). Healthcare providers turn to GPOs in order to save time and 
money necessary to negotiate thousands of individual contracts (Supply Chain 
Association, 2015). This however, seems to make it harder for some of the interviewed 
OEMs to get first-hand information on customer needs, and on the side of the consumer, 
a greater role for physicians and governments has been considered necessary to ensure 
that technologies procured by GPOs best meet patient needs and are aligned with national 
health care priorities (Sorenson & Kanavos, 2011). Several respondents considered this 
factor as a decisive point, as the success of their innovations depends on how well they 
understand their customers (both national and international customers), and the 
complexity of their supply chain depends, consequently, on the configuration of those 
innovations.  
Company A recognised the importance of CRM and launched a project between sales, 
marketing, design and prototyping as well as representatives of the customer in order to 
generate a clear agreement and rules in the relationship with the end customer. To this 
effect, regular meetings with customers and shared information systems were key 
elements of this project. In this context, the role of the design department was highlighted 
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as well, with customers (physicians) participating in the conception and design of new 
technologies. Company D’s strategy towards more accurate demand forecasts involved 
the foundation of a strategic alliance with both physicians and healthcare providers.  
Based on these findings, authors suggest that CRM reduces the complexity of supply 
chain operations and can lead to new business models that German MT SMEs have yet 
to exploit.  
For these reasons, we propose that: 
 
P5. German Medical Technology OEMs require a shift from pure cost-orientation 
to service-orientation in order to remain competitive in the market. This is not 
limited to the strategic involvement of physicians and managers in issues such as 
product design, but also by designing and implementing tailor-made concepts for 
logistical supply and after sales services.   
 
4.6 Speed to market and better flexibility are imperative elements of the production 
system of Medical Technology OEMs 
The objective of an integrated production system is to produce more products in the same 
or shorter time with less cost while ensuring the expected quality. This is possible when 
work cycles are as short as possible and all non-added value activities are eliminated or 
at the very least, reduced. This results in shorter lead times, less work-in-process, and 
higher productivity for an organisation, which translates into a better responsiveness of 
its supply chain (Schönheit, 1997). Company D mentions that a key element to achieve 
agile, flexible supply chains is a production system that supports them, especially when 
several links of the supply chain belong to the same firm. Concentrating on changing 
previous management culture, refining target systems and ensuring process orientation 
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within the organisation were the key elements of the implementation of their production 
system in several sites.  
Focusing on added-value activities in the supply chain is critical and restructuring these 
activities can provide opportunities for improvement (Thomas & Griffin, 1996). 
Company M was on the verge of losing a customer due to late deliveries. After the 
implementation of a Lean Production System in all of their manufacturing plants 
worldwide (an endeavour that took almost two years), the company was able to improve 
their on-time-delivery rates by 30% while reducing their fixed costs by 20%.  
 
Slow and long supply chains hinder a company’s ability to respond quickly to customer 
demand and, as the life cycles of medical devices are very short, manufacturers face the 
risk of inventory obsolescence (Thomas & Griffin, 1996; Li et al., 2008). For this reason, 
both Companies C and H have focused on improving material flow by streamlining their 
value streams starting from their suppliers to their distribution centres. They also have 
focused on carefully defining the information requirements between organisations and 
the instruments used to transfer this information. The results were overwhelming for both 
organisations: shorter delivery times, extra capacity for new orders, less stock between 
processes and a higher turnover rate of stored raw materials and components. However, 
the consequences of implementing a more agile production system should also be 
discussed and agreed with upstream business partners, as one-sided expectations of 
OEMs regarding inventory reduction at their level can bring about disruptions to their 
suppliers. Company G engaged in the transformation of its production system over a 
period of 30 months, resulting in an impressive reduction of lead times from 6 days to 1 
day, a reduction of space requirements by 60%, and a reduction of stocks by 30%, all 
measures that decreased their customer order backlog dramatically. As their customer 
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order backlog sunk and their inventory levels dropped down, Company G changed their 
behaviour of raw materials and components consumption, leading to more irregular 
demand schedules for three of its suppliers, who found themselves struggling to balance 
erratic demand changes with their manufacturing capacities.  
Based on these findings, it is proposed that: 
 
P6. Agile production systems that focuses on speed to market and flexibility are 
better suited to support German MT supply chains, as product life cycles are 
shorter than in other industries. However, consequences of these process changes 
should be agreed with upstream business partners in order to create win-win 
scenarios and long-lasting relationships. 
 
 
5. Conclusions  
MTSCs have received limited coverage in the existing SCM literature, subsumed by 
generic supply chain research interests. However, in light of the increasing recognition of 
the importance of healthcare systems, their efficiencies and effectiveness, MTCSs have a 
key contribution to make. This research is an initial attempt to contribute empirically and 
practically to not only the wider body of SCM literature, but also work on CSFs along 
with sectoral focus on medical technologies.  
 
This paper’s contribution to theory is threefold. Firstly, the findings indicate that there 
are six CSFs for German Medical Technology OEMs, prioritised as follows: (1) sales and 
operations planning, (2) product development process, (3) quality and compliance, (4) 
procurement strategies, (5) customer relationship management, and (6) production 
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systems. Secondly, the outcome of this study suggests that the combination of these CSFs 
leads to better performance of OEMs in the Medical Technology sector. CSFs have been 
the subject of previous research in the field of SCM but none has investigated the 
important and growing Medical Technology sector, which recent literature has labelled 
as ‘supply chain laggards’ (Mayr, 2013); this study provides elaboration and practitioner 
insight from the perspective of both LEs and SMEs of the German Medical Technology 
sector. Thirdly, this paper also clarifies a shift in our understanding of the importance of 
several CSFs to practitioners, such as information management and inventory 
management, which have been previously been perceived as more important than they 
actually are. Importantly, this study highlights pre-eminent factors for the success of SCM 
which have not been adequately recognised by previous research, in particular: quality 
and compliance, product development process, and production system.  
 
Each of the identified CSFs is summarised in six testable propositions (Table 6). These 
propositions serve as a starting point for further scholarly inquiry into the supply chains 
of this industry sector. These propositions also show that in order to increase value for 
the OEMs of this sector, an integrated approach is essential. It is not the implementation 
of isolated projects that improves a supply chain, but rather the careful selection of the 
appropriate and targeted measures in order to allocate resources in a more efficient and 
effective way.  
 
 
 
 
 
 
Research Propositions 
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P1 Issues of balancing customer demand requirements and capacity allocation in the supply chain 
are raised by conflicting goals between departments within an OEM and between organisations 
in the supply chain of German MT. OEMs focusing on installing sustainable and robust Sales 
and Operation Planning systems have a competitive advantage over those who do not. 
P2 In order to reduce complexity of future operations, product design requires not only the 
involvement of physicians, health institutions, and regulatory agencies to enhance product 
functionality, but also the involvement of stakeholders of the supply chain, particularly 
manufacturing, sourcing, logistics, sales, and after sales services. 
P3 As supply chain visibility is a capability that customers are increasingly willing to pay for, 
selecting the appropriate tools requires process orientation. Providing hospitals and clinics with 
real-time information on product and spare parts shipping status can provide a competitive 
advantage for OEMs in the Medical Technology sector. 
P4 Although procurement strategies such as VMI, Kanban, and JIT appear to be more beneficial for 
large German firms with power over suppliers, SMEs require their procurement strategies to be 
based on the product lifecycle in order to reduce the risk of inventory obsolescence. Cooperation 
and process knowledge exchange is beneficial for both OEMs and upstream organisations when 
designing and implementing alternative procurement strategies.   
P5 German Medical Technology OEMs require a shift from pure cost-orientation to service-
orientation in order to remain competitive in the market. This is not limited to the strategic 
involvement of physicians and managers in issues such as product design, but also by designing 
and implementing tailor-made concepts for logistical supply and after sales services.   
P6 Agile production systems that focuses on speed to market and flexibility are better suited to 
support German MT supply chains, as product life cycles are shorter than in other industries. 
However, consequences of these process changes should be agreed with upstream business 
partners in order to create win-win scenarios and long-lasting relationships. 
 
Table 6: Research propositions 
 
 
This paper provides empirical evidence about which strategies are being used by 
practitioners in the MT sector in order to improve the performance of their supply 
networks. Managers can use this work as a guideline to develop or restructure their own 
supply chain policies. The insights from the case study organisations documented in this 
research will be of interest to organisations both in and beyond this sector. The identified 
CSFs offer new priorities for management practice to consider, particularly if they are 
currently considering re-examining, adjusting or setting up new supply chain strategies. 
 45 
 
Furthermore, this work will potentially be relevant to those organisations operating in 
industries which are characterised by high regulation. 
 
 
6. Limitations and Future Research  
 
One limitation of this study is that the target group of the case study was the head of the 
SCM operation of each case company. Although researchers were involved in the 
discussions in order to overcome this limitation, the insights provided by this respondent 
group may not be representative of the perceptions of other stakeholders in the MTSC. 
An additional limitation is the fact that it only represents the context of German MTSCs. 
Future research into the Medical Technology sector should seek widening studies that 
include other countries in order to gain a better understanding of the Medical Technology 
supply chain as a whole and thus enhance the generalisability of the research findings.   
There is great scope for further research that would build upon work in this area. The first 
entails using the results of this research in order to compare and contrast MTSCs in the 
US and Japan – the other major global MTSCs. Such a study could assist in overcoming 
the lack of generalisability of this research and test the relationships established in this 
paper. Future research could also provide further investigation into the relationship 
between the identified CSFs and the results achieved after implementing strategies based 
on these factors.  Further important work should test the six propositions advanced by this 
work. Finally, given the literature gap regarding CSFs in MTSCs, additional research 
could assist in providing further understanding of the drivers, barriers, processes and 
benefits within this context.  
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